{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:08:20Z","timestamp":1780574900341,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omtm.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T21:25:26Z","timestamp":1594243526000},"page":"664-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease"],"prefix":"10.1016","volume":"18","author":[{"given":"Chady H.","family":"Hakim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakmini P.","family":"Wasala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao T.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasun","family":"Kodippili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Adamson-Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Nora","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.07.004_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/hum.2005.16.401","article-title":"Adeno-associated virus: a ubiquitous commensal of mammals","volume":"16","author":"Flotte","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ymthe.2004.09.011","article-title":"Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective","volume":"10","author":"Carter","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2020.07.004_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.07.004_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2020.07.004_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/1566523054064977","article-title":"Helper functions required for wild type and recombinant adeno-associated virus growth","volume":"5","author":"Geoffroy","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib7","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1073\/pnas.78.3.1925","article-title":"Locations of adenovirus genes required for the replication of adenovirus-associated virus","volume":"78","author":"Janik","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.07.004_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtm.2020.07.004_bib9","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.07.004_bib10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.gt.3300680","article-title":"Adeno-associated virus vectors can be efficiently produced without helper virus","volume":"5","author":"Matsushita","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib11","first-page":"095596","article-title":"Production of recombinant adeno-associated viruses (rAAVs) by transient transfection","volume":"2020","author":"Su","year":"2020","journal-title":"Cold Spring Harb. Protoc"},{"key":"10.1016\/j.omtm.2020.07.004_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-61779-343-1_15","article-title":"Recombinant adeno-associated viral vector production and purification","volume":"798","author":"Shin","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2020.07.004_bib13","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1089\/hum.1998.9.18-2745","article-title":"Novel tools for production and purification of recombinant adenoassociated virus vectors","volume":"9","author":"Grimm","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/hum.2009.064","article-title":"Transient transfection methods for clinical adeno-associated viral vector production","volume":"20","author":"Wright","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coviro.2016.07.006","article-title":"Systemic delivery of adeno-associated viral vectors","volume":"21","author":"Duan","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omtm.2020.07.004_bib16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward gene therapy for Duchenne muscular dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/hum.2018.012","article-title":"Micro-dystrophin gene therapy goes systemic in Duchenne muscular dystrophy patients","volume":"29","author":"Duan","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/hum.2009.092","article-title":"Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy","volume":"20","author":"Virag","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1089\/hum.2009.094","article-title":"Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies","volume":"20","author":"Cl\u00e9ment","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1089\/hum.2009.125","article-title":"Adenovirus-adeno-associated virus hybrid for large-scale recombinant adeno-associated virus production","volume":"20","author":"Zhang","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.omtm.2017.11.002","article-title":"A robust system for production of superabundant VP1 recombinant AAV vectors","volume":"7","author":"Wang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.07.004_bib22","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1101\/pdb.prot5496","article-title":"Stable producer cell lines for adeno-associated virus (AAV) assembly","volume":"2010","author":"Chadeuf","year":"2010","journal-title":"Cold Spring Harb. Protoc"},{"key":"10.1016\/j.omtm.2020.07.004_bib23","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/jmbi.1995.0152","article-title":"Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses","volume":"247","author":"McGeoch","year":"1995","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtm.2020.07.004_bib25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0042-6822(90)90130-J","article-title":"Adeno-associated virus DNA replication is induced by genes that are essential for HSV-1 DNA synthesis","volume":"179","author":"Mishra","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.omtm.2020.07.004_bib26","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1128\/jvi.65.5.2476-2483.1991","article-title":"A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication","volume":"65","author":"Weindler","year":"1991","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.07.004_bib27","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1128\/JVI.75.21.10250-10258.2001","article-title":"Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system","volume":"75","author":"Ward","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.07.004_bib28","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1128\/jvi.71.11.8780-8789.1997","article-title":"Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap","volume":"71","author":"Conway","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.07.004_bib29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/sj.gt.3300937","article-title":"High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap","volume":"6","author":"Conway","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.omtm.2017.06.006","article-title":"A five-repeat micro-dystrophin gene ameliorated dystrophic phenotype in the severe DBA\/2J-mdx model of Duchenne muscular dystrophy","volume":"6","author":"Hakim","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.07.004_bib31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of novel micro-dystrophins with enhanced functionality","volume":"27","author":"Ramos","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib32","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1038\/mtm.2016.31","article-title":"A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform","volume":"3","author":"Adamson-Small","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.07.004_bib33","doi-asserted-by":"crossref","first-page":"14034","DOI":"10.1038\/mtm.2014.34","article-title":"A simplified purification protocol for recombinant adeno-associated virus vectors","volume":"1","author":"Potter","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.07.004_bib34","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2353\/ajpath.2008.071042","article-title":"Preservation of muscle force in mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein","volume":"172","author":"Li","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2020.07.004_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ymthe.2004.09.013","article-title":"Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury","volume":"11","author":"Liu","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib36","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1542\/peds.2010-0929","article-title":"Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy","volume":"127","author":"McMillan","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2020.07.004_bib37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3122\/jabfm.2012.04.110183","article-title":"Consider muscle disease in children with elevated transaminase","volume":"25","author":"Wright","year":"2012","journal-title":"J.\u00a0Am. Board Fam. Med."},{"key":"10.1016\/j.omtm.2020.07.004_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nmd.2013.09.004","article-title":"Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: results of a double-blind randomized clinical trial","volume":"24","author":"Flanigan","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2020.07.004_bib39","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/liv.13441","article-title":"The transformation in biomarker detection and management of drug-induced liver injury","volume":"37","author":"Church","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.omtm.2020.07.004_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/428143","article-title":"2004 William Allan award address. cloning of the DMD gene","volume":"76","author":"Kunkel","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.07.004_bib41","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1093\/hmg\/ddv310","article-title":"Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus","volume":"24","author":"Yue","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.07.004_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtm.2020.07.004_bib43","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.07.004_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10974-019-09535-9","article-title":"What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy?","volume":"40","author":"Wells","year":"2019","journal-title":"J.\u00a0Muscle Res. Cell Motil."},{"key":"10.1016\/j.omtm.2020.07.004_bib45","first-page":"251","article-title":"Dystrophin levels required for correction of Duchenne muscular dystrophy","volume":"7","author":"Chamberlain","year":"1997","journal-title":"Basic Appl. Myol."},{"key":"10.1016\/j.omtm.2020.07.004_bib46","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.jpeds.2013.08.004","article-title":"Patterns of growth in ambulatory males with Duchenne muscular dystrophy","volume":"163","author":"West","year":"2013","journal-title":"J.\u00a0Pediatr"},{"key":"10.1016\/j.omtm.2020.07.004_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpn.2013.08.008","article-title":"Growth and psychomotor development of patients with Duchenne muscular dystrophy","volume":"18","author":"Sarrazin","year":"2014","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"R1","key":"10.1016\/j.omtm.2020.07.004_bib48","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1093\/hmg\/ddr141","article-title":"Large-scale recombinant adeno-associated virus production","volume":"20","author":"Kotin","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"R1","key":"10.1016\/j.omtm.2020.07.004_bib49","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddv451","article-title":"Progress and challenges in viral vector manufacturing","volume":"25","author":"van der Loo","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.07.004_bib50","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1038\/mtm.2016.2","article-title":"Manufacturing of recombinant adeno-associated viral vectors for clinical trials","volume":"3","author":"Cl\u00e9ment","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.07.004_bib51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.omtm.2018.01.002","article-title":"Pharmacology of recombinant adeno-associated virus production","volume":"8","author":"Penaud-Budloo","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.07.004_bib52","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.07.004_bib53","doi-asserted-by":"crossref","first-page":"e15286","DOI":"10.1371\/journal.pone.0015286","article-title":"Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin\/utrophin double knockout mice","volume":"5","author":"Li","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.07.004_bib54","doi-asserted-by":"crossref","first-page":"e31937","DOI":"10.1371\/journal.pone.0031937","article-title":"The effects of low levels of dystrophin on mouse muscle function and pathology","volume":"7","author":"van Putten","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.07.004_bib55","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1096\/fj.12-224170","article-title":"Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin\/utrophin double-knockout mice","volume":"27","author":"van Putten","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2020.07.004_bib56","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1089\/hum.2019.29099.rmk","article-title":"Recombinant adeno-associated virus quality control for non-clinical and clinical vectors: how an unregulated commercial sector can compromise development of new gene therapies","volume":"30","author":"Kotin","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.004_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/hgtb.2016.188","article-title":"Improving the quality of adeno-associated viral vector preparations: the challenge of product-related impurities","volume":"28","author":"Schn\u00f6dt","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2020.07.004_bib58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21873","article-title":"Genotyping mdx, mdx3cv, and mdx4cv mice by primer competition polymerase chain reaction","volume":"43","author":"Shin","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2020.07.004_bib59","first-page":"Unit 20.3","article-title":"Calcium phosphate transfection. Curr. Protoc","volume":"Chapter 20","author":"Kingston","year":"2003","journal-title":"Cell Biol"},{"key":"10.1016\/j.omtm.2020.07.004_bib60","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2020.07.004_bib61","doi-asserted-by":"crossref","first-page":"e88280","DOI":"10.1371\/journal.pone.0088280","article-title":"Characterization of 65 epitope-specific dystrophin monoclonal antibodies in canine and murine models of duchenne muscular dystrophy by immunostaining and western blot","volume":"9","author":"Kodippili","year":"2014","journal-title":"PLoS ONE"},{"issue":"72","key":"10.1016\/j.omtm.2020.07.004_bib62","first-page":"50183","article-title":"Evaluation of muscle function of the extensor digitorum longus muscle ex\u00a0vivo and tibialis anterior muscle in\u00a0situ in mice","author":"Hakim","year":"2013","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.omtm.2020.07.004_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-61737-982-6_5","article-title":"Monitoring murine skeletal muscle function for muscle gene therapy","volume":"709","author":"Hakim","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2020.07.004_bib64","first-page":"184","article-title":"Density and composition of mammalian muscle","volume":"9","author":"Mendez","year":"1960","journal-title":"Metabolism"},{"key":"10.1016\/j.omtm.2020.07.004_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jmor.1052210207","article-title":"Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb","volume":"221","author":"Burkholder","year":"1994","journal-title":"J.\u00a0Morphol."},{"key":"10.1016\/j.omtm.2020.07.004_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1113\/jphysiol.1988.sp017279","article-title":"Contractile properties of skeletal muscles from young, adult and aged mice","volume":"404","author":"Brooks","year":"1988","journal-title":"J.\u00a0Physiol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:26:01Z","timestamp":1762421161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120301534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":66,"alternative-id":["S2329050120301534"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.07.004","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}